IDT Acquires Oligonucleotide Synthesis Company ValueGene
News Jun 13, 2016
Integrated DNA Technologies has announced the acquisition of ValueGene, Inc. (“ValueGene”), an oligonucleotide synthesis services company based in San Diego, California.
ValueGene offers custom DNA and RNA oligonucleotide synthesis products, including PAGE and HPLC purification and modification services.
Dr Joseph A Walder, IDT founder and chief executive officer, said, “We look forward to maximizing the synergies between our two companies and building on ValueGene’s long history of providing quality products and services to its customers.”
Dan Dernbach, general manager of IDT’s West Coast operations, added, “ValueGene is well known in San Diego and Los Angeles. We welcome the opportunity to serve ValueGene’s customers and provide them the benefit of our portfolio of reagents for genomics research to support their important discoveries.”
Longze Cui of ValueGene said, “We are pleased to join IDT and are confident our customers will experience a smooth transition. Our customers, and their satisfaction, are our top priorities.”
China is poised to introduce a new regulation on gene editing in humans. A draft of the country’s new civil code lists human genes and embryos in a section on personality rights to be protected. Experiments on genes in adults or embryos that endanger human health or violate ethical norms can accordingly be seen as a violation of a person’s fundamental rights.READ MORE